市販のインドールから誘導するケース、インドール骨格の構築等、多数実績があります。
Fischer Indole Synthesis
弊社では最近、Cyanine系蛍光色素の合成に力を入れているため合成実績の多くはFischer法ですが他にも様々なアプローチの合成経験が多数あり、最適な方法を選択することでご希望の構造を合成できると考えております。
Bischler Indole Synthesis
Bishler-Mohlau Indole Synthesis
Nenitzescu 5-Hydrozyindole Synthesis
Hemetsberger-Knittel Indole synthesis
Nenitzescu Indole Synthesis
Saegusa-Ito Indole Synthesis
Gassman Indole Synthesis
Hinsberg-Stolle Indole-Oxindole Synthesis
Bartoli Indole Synthesis
Batcho-Leimgruber Indole synthesis
Hegedus Indole synthesis
Mori-Ban Indole Synthesis
Reissert Indole Synthesis
Walser Indole Synthesis
Madelung Indole Synthesis
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 06396 |  | AADIS7-PEG13-COOH | 133,800/0.1mg | >95% | 0.3 |
| 04720 |  | Cy5(1-Hex-CONH-PEG13-COOtBu 8,8-diMe 1'-Me 8',8'-diMe) | 67,400/0.1mg | >90% | 1.5 |
| 06518 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 69,600/0.1mg | >90% | 0 |
| 06069 |  | TMSI-PEG10-OH | 69,600/0.1mg | >95% | 0.1 |
| 06068 |  | TMSI-PEG10-OTrt | 64,200/0.2mg | >95% | 9.0 |
| 06295 |  | TMSI-PEG8-OH | 64,800/0.7mg | >95% | 12.8 |
| 06516 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >90% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06417 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06520 |  | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 69,600/0.1mg | >90% | 0 |
| 06426 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06419 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >90% | 0 |
| 06418 |  | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 69,600/0.1mg | >95% | 0 |
| 06523 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06522 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06519 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 69,600/0.1mg | >95% | 0 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 69,600/0.1mg | >90% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06433 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 69,600/0.1mg | >90% | 0 |
| 06422 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >90% | 0 |
| 06293 |  | TMSI-PEG4-Pr-COOH | 64,800/0.7mg | >95% | 0 |
| 06062 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 106,300/0.1mg | >95% | 0.1 |
| 06059 |  | AADIS7-PEG4-COOMe | 133,800/0.1mg | >95% | 3.9 |
| 06009 |  | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 106,300/0.1mg | >95% | 0 |
| 05970 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 69,600/0.1mg | >95% | 0 |
| 05948 |  | TMSI-PEG4-OH | 69,600/0.2mg | >95% | 15.7 |
| 05075 |  | AADIS7-PEG3-OAc | 66,500/0.4mg | >95% | 3.0 |
| 03545 |  | TMSI-PEG4-COOMe | 69,600/0.1mg | >95% | 1.6 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 69,600/0.1mg | >90% | 0 |
| 06431 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06430 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >90% | 0 |
| 06425 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06423 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06061 |  | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 106,300/0.1mg | >95% | 0.1 |
| 05146 |  | TMSI-PEG3-OH | 69,600/0.1mg | >95% | 89.4 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06510 |  | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 69,600/0.1mg | >95% | 0 |
| 06440 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >95% | 0 |
| 06439 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 69,600/0.1mg | >90% | 0 |
| 06460 |  | TMI-PEG1-COOtBu | 65,700/7.5mg | >95% | 272.0 |
| 06459 |  | TMI-PEG1-COOEt | 65,700/7.5mg | >95% | 258.2 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 133,800/0.1mg | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 69,600/0.1mg | >95% | 0 |
| 06438 |  | Cy7(1-HexCOOH 8,8-diMe 1'-Me 8',8'-diMe)(3,5-Pr-cyclic) | 133,800/0.1mg | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 69,600/0.1mg | >95% | 0 |
| 06337 |  | AADI7-Et-OH | 64,800/0.7mg | >95% | 399.4 |
| 06336 |  | TMI-Et-OH | inquire | >90% | 2,799.9 |
| 06297 |  | AADIS5-Et-OAc | 69,600/0.2mg | >95% | 8.0 |
| 06296 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 106,300/0.1mg | >90% | 0.9 |
| 06114 |  | AADIS7-Et-SO3H | 69,600/0.1mg | >80% | 7.6 |
| 06035 |  | TMSI-Et-SO3H | 66,500/0.4mg | >80% | 20.4 |
| 05969 |  | AADIS5-Hex-COOH | 64,800/0.7mg | >95% | 1.0 |
| 05959 |  | AADIS5-Me | 69,600/0.2mg | >95% | 9.3 |
| 05954 |  | AADIS7-Hex-COOH | 69,600/0.1mg | >95% | 0.1 |
| 05945 |  | TMSI-acetoxyacetic acid | 69,600/0.1mg | >95% | 5.3 |
| 05944 |  | TMSI-Me | inquire | >95% | 3.3 |
| 05941 |  | AADIS5-HexCOOH | 64,800/0.7mg | >95% | 31.2 |
| 05364 |  | AADIS5-Et-SO3H | 106,300/0.1mg | >95% | 2.4 |
| 05147 |  | Sulfo Cy3-diamine | 69,600/0.2mg | >95% | 5.0 |
| 05142 |  | TMSI-Et-OH | 67,100/2.5mg | >95% | 325.6 |
| 05141 |  | TMSI-acetic acid | 64,200/0.2mg | >95% | 13.3 |
| 05132 |  | TMSI-Et-NH2 | 69,600/5mg | >95% | 22.7 |
| 05072 |  | AADIS7-Me | 64,200/0.2mg | >95% | 1.7 |
| 04136 |  | TMSI-Hex-COOH | inquire | >90% | 740.6 |
| 04132 |  | DMSI(3-Hex-COOH) | 69,600/5mg | >90% | 525.4 |
| 03607 |  | TMSI-K salt | inquire | >90% | 3,225.9 |
| 02837 |  | 4-(4-methoxyphenyl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]indole | 68,900/0.2mg | >80% | 750.0 |
| 02834 |  | 1,2,3,4-tetrahydrocyclopent[b] indole | inquire | >80% | 1.0 |
| 01980 |  | Cy3-halolinker | 64,200/0.2mg | >95% | 0.1 |
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 04937 |  | 3-Bromo-2,2-bis(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanol, O-triphenylmethyl | 76,800/0.1mg | >95% | 50.0 |
| 03390 |  | Indigo | 64,200/50mg | >90% | 31.8 |
